Brief: Cardiff Oncology Reports First-Quarter 2023 Results And Provides Business Update
04/05/2023 22:15
May 4 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS FIRST-QUARTER 2023 RESULTS AND
PROVIDES
BUSINESS UPDATE
* CARDIFF ONCOLOGY INC - BELIEVES ITS CURRENT CASH RESOURCES
ARE
SUFFICIENT TO FUND ITS OPERATIONS INTO 2025
* CARDIFF ONCOLOGY INC - TOTAL OPERATING EXPENSES WERE
APPROXIMATELY $12.1 MILLION FOR THREE MONTHS ENDED MARCH 31 2023
Source text for Eikon: ID:nPn19DpHGa
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering